Hanshinnocol
NDC Package 53153-101-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Hanshinnocol is a . Marketed by Han Kook Shin Yak Pharmaceutical Co., Ltd., this product is identified by NDC 53153-101 and is authorized under FDA application part341.

Identification & Billing

NDC Package Code
53153-101-05
Package Description
10 BOX in 1 CARTON / 3 BOTTLE in 1 BOX (53153-101-04) / 30 mL in 1 BOTTLE (53153-101-01)
Product Code
11-Digit Billing Format
53153010105

Clinical Specifications

Proprietary Name
Hanshinnocol
Dosage Form
-

Regulatory & Marketing

Labeler Name
Han Kook Shin Yak Pharmaceutical Co., Ltd.
FDA Application #
part341
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
06-30-2015
End Marketing Date
06-10-2021
Listing Expiration
06-10-2021
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53153-101-05 identifies a specific commercial package of 10 box in 1 carton / 3 bottle in 1 box (53153-101-04) / 30 ml in 1 bottle (53153-101-01) of Hanshinnocol, labeled by Han Kook Shin Yak Pharmaceutical Co., Ltd.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Han Kook Shin Yak Pharmaceutical Co., Ltd. on June 30, 2015. The current certification is valid through June 10, 2021.

How is this Han Kook Shin Yak Pharmaceutical Co., Ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53153010105. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
53153-101-05
11-Digit CMS (5-4-2)
53153-0101-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.